Facebook Pixel Get public-private partnerships right for target-oriented growth | Mint Chennai - newspaper - Lees dit verhaal op Magzter.com
Ga onbeperkt met Magzter GOLD

Ga onbeperkt met Magzter GOLD

Krijg onbeperkte toegang tot meer dan 9000 tijdschriften, kranten en Premium-verhalen voor slechts

$149.99
 
$74.99/Jaar

Poging GOUD - Vrij

Get public-private partnerships right for target-oriented growth

Mint Chennai

|

January 06, 2025

The UK's new government should engage the private sector with deals that achieve public objectives

- MARIANA MAZZUCATO

The UK's Labour government has given serious thought to the public investment needed to get the economy back on track after 14 years of austerity, neglect of social infrastructure and capital flight triggered by Brexit and economic uncertainty. The situation demands a new strategy to tackle big problems like child poverty, health inequities, a weak industrial base and struggling public infrastructure.

What should this look like? The UK department for business and trade's 'green paper' titled 'Invest 2035' is a promising start. In my own response during the public consultation period, I stressed that an industrial strategy should be oriented around key missions like achieving net-zero emissions, rather than specific sectors, as London appears to be doing; while it has set itself five 'missions,' they seem more like goals with some targets, rather than being central to the way government and industry work together.

For Labour to deliver on its agenda, it must get its public-private partnerships (PPPs) right. Past collaborations in the UK had the state overpaying and private sector under-delivering. After the Brexit referendum, for example, the government gave Nissan £61 million to make cars in the UK. But Nissan still abandoned a planned expansion at its Sunderland plant and the promised jobs never materialized.

MEER VERHALEN VAN Mint Chennai

Mint Chennai

Mint Chennai

Barrier-free tolling runs into a Chinese camera security bump

Commuters looking to zoom past toll plazas on India's 146,560 km highway network will have to wait longer.

time to read

1 min

February 26, 2026

Mint Chennai

A new grammar to challenge Tamil film

Members of the Problematic Family, which premiered at the Berlinale, is a striking, experimental debut film from R. Gowtham

time to read

3 mins

February 26, 2026

Mint Chennai

AUROBINDO PHARMA TAKES A PENICILLIN SHOT

The company has made a ₹2,500 crore bet to rebuild its antibiotic backbone. Will it work?

time to read

6 mins

February 26, 2026

Mint Chennai

Digital rupee pilot for food subsidy

In a significant shift in the way food subsidies are delivered, the government will launch a central bank digital currency (CBDC)-based pilot under the Pradhan Mantri Garib Kalyan Anna Yojana (PMGKAY) in Puducherry on 26 February.

time to read

1 min

February 26, 2026

Mint Chennai

DRL's obesity jab may launch in March

Dr. Reddy's Laboratories (DRL) is likely to launch its generic semaglutide injection in the country in March under the brand name Obeda, according to two people familiar with the matter as well as images reviewed by Reuters.

time to read

1 min

February 26, 2026

Mint Chennai

Mint Chennai

Uranium supply deal likely during Carney’s India visit

Cameco CEO Tim Gitzel to be part of the business delegation accompanying Canadian PM

time to read

2 mins

February 26, 2026

Mint Chennai

Mint Chennai

Warner interested in Paramount offer

Warner Bros Discovery Inc. said a new $31-a-share buyout offer from Paramount Skydance Corp. could lead to a better deal than its existing agreement with Netflix Inc., kicking off another potential round of bidding for the famed Hollywood studio.

time to read

1 mins

February 26, 2026

Mint Chennai

Mint Chennai

Hype and havoc shroud Al's impact on IT firms

Is investor anxiety over the business models of IT service companies being rendered obsolete by AI overblown? The truth lies between an apocalypse and AI-impact denial. Here's why

time to read

2 mins

February 26, 2026

Mint Chennai

Mint Chennai

Zydus plans obesity jab in pens after semaglutide patent ends

Ahmedabad-based drugmaker Zydus Lifesciences plans to launch its semaglutide injection brands upon patent expiry of the drug in India.

time to read

1 mins

February 26, 2026

Mint Chennai

Mint Chennai

CHASING 12% EQUITY RETURNS? LONG-TERM INVESTING ISN'T JUST ABOUT A NUMBER

Most investors enter equity mutual funds expecting an annual average return of about 12%.

time to read

3 mins

February 26, 2026

Listen

Translate

Share

-
+

Change font size